A Dual‐Strategy Hydrogel Targeting Glycolytic Reprogramming and Inflammation to Inhibit Ferroptosis and Promote Intervertebral Disc Repair
Small · 2026-04 · 22 (24)
DOI: 10.1002/smll.202514952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 03.03.2026. Verfasst von Dengbo Yao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Ferroptosis, Inflammation, Glycolysis, Hydrogels. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Postdoctoral Research project, West China Hospital, Sichuan University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Intervertebral disc degeneration (IVDD) is a major cause of lower back pain, and its progression is largely driven by metabolic changes, particularly enhanced glycolysis. Lactate, a by‐product of glycolysis, induces ferroptosis in nucleus pulposus cells (NPCs). Inflammation further enhances glycolysis in NP cells and upregulates lactate dehydrogenase A (LDHA), leading to increased lactate accumulation and the formation of a vicious cycle that accelerates IVDD progression. In this study, an innovative dual‐strategy hydrogel system was designed to address these limitations. Phenylboronic acid (PBA) ‐functionalized G5 PAMAM (G5‐PBA) was used to encapsulate LDHA siRNA (siLDHA), forming self‐assembled nanoparticles (GPS). Subsequently, GPS was modified with epigallocatechin (EGC) to form stable GPS‐EGC nanoparticles through borate ester bonds. The nanoparticles were then incorporated into a reactive oxygen species‐ and pH‐responsive hydrogel, enabling controlled and sustained drug release. By combining metabolic reprogramming with anti‐inflammatory strategies, the designed system not only reduced IL‐1β‐induced inflammation and lactate production but also alleviated ferroptosis in NPCs and promoted tissue repair in IVDD models. This approach offers a promising therapeutic strategy for IVDD and highlights the potential of material innovation in modulating both metabolic and inflammatory pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Department of Stomatology, Sichuan Taikang Hospital, Chengdu, Sichuan, China.
- West China School of Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Department of Radiology, Sichuan Taikang Hospital, Chengdu, Sichuan, China.
ORCID-Profile: Dengbo Yao, Qingquan Kong
Förderung
- China Postdoctoral Science Foundation
- Postdoctoral Research project, West China Hospital, Sichuan University
- National Natural Science Foundation of China
Zitieren
APA
Yao, D., Tang, Y., Chen, H., Yao, J., Zhao, Z., Liu, H., Ma, F., Liu, Y., Wang, Y., & Kong, Q. (2026). A Dual‐Strategy Hydrogel Targeting Glycolytic Reprogramming and Inflammation to Inhibit Ferroptosis and Promote Intervertebral Disc Repair. Small, 22(24). https://doi.org/10.1002/smll.202514952
Vancouver
Yao D, Tang Y, Chen H, Yao J, Zhao Z, Liu H, et al. A Dual‐Strategy Hydrogel Targeting Glycolytic Reprogramming and Inflammation to Inhibit Ferroptosis and Promote Intervertebral Disc Repair. Small. 2026;22(24). doi:10.1002/smll.202514952
BibTeX
@article{Yao2026,
author = {Yao, Dengbo and Tang, Yu and Chen, Houqi and Yao, Juntao and Zhao, Zhen and Liu, Hang and Ma, Fei and Liu, Yuheng and Wang, Yu and Kong, Qingquan},
title = {A Dual‐Strategy Hydrogel Targeting Glycolytic Reprogramming and Inflammation to Inhibit Ferroptosis and Promote Intervertebral Disc Repair},
journal = {Small},
year = {2026},
volume = {22},
number = {24},
doi = {10.1002/smll.202514952}
}
EUVIMED